Pittsburgh-based UPMC is teaming up with natural language understanding company Realyze Intelligence to study whether an invasive procedure is the right diagnostic tool for certain cancer patients. Realyze is a portfolio company of UPMC Enterprises, the health system’s venture capital arm.
Read the full post on Becker's Hospital Review - Healthcare News
